| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |